This article is from the WebMD News Archive
Happier With Sex Life: Men or Women?
April 19, 2006 -- All over the world, men are more satisfied with their sex lives than women, a new study shows.
The study included 13,882 women and 13,618 men in 29 countries. All participants were at least 40 years old.
No matter where participants lived, men generally rated their sexual well-being higher than women, write the University of Chicago's Edward Laumann, PhD, and colleagues.
Participants completed surveys on their "sexual well-being," which was defined as the physical and emotional satisfaction of sexual relationships, satisfaction with sexual health or function, and the importance of sex in one's life.
Women rated themselves lower than men in all of those categories, Laumann's team reports in the Archives of Sexual Behavior.
International Sex Survey
Participants were randomly chosen. They were told that their answers would be confidential.
Survey questions included:
- "Generally, how happy have you been with your life as a whole [physical, social, family, work] during the past 12 months?"
- "During the past 12 months, how physically pleasurable did you find your relationship with your partner to be?"
- "During the past 12 months, how emotionally satisfying did you find your relationship with your partner to be?"
- "If you were to spend the rest of your life with your sexual function/sexual health the way it is today, how would you feel about this?"
Participants also rated how strongly they agreed or disagreed with statements including:
- "Older people no longer want sex."
- "A 'real man' is ready for sex at any time."
- "Women have greater control over sexual desires than men."
- "Women have a duty to meet their partner's sexual needs."
World's Views on Sexual Well-Being
The researchers split the countries into three clusters, which included:
- Cluster 1: Western Europe, Mexico, Australia, Canada, New Zealand, South Africa, U.S.
- Cluster 2: Algeria, Egypt, Israel, Italy, Morocco, Turkey, Korea, Malaysia, the Philippines, Brazil.
- Cluster 3: China, Indonesia, Japan, Taiwan, Thailand.
The countries in cluster 1 had the highest ratings of sexual satisfaction, but cluster 2 attributed more importance to sex than the other groups, the researchers write. Cluster 3 ranked lowest in all categories on the survey.
Cultural differences in sexual attitudes, practices, and sexual well-being between "East" and "West" deserve more study, the researchers write.
Participants who rated their health as being good also gave their sex lives better ratings. Health was a bigger influence than age, the study shows.
As for the gender gap, Laumann's team writes that "true parity remains an ideal even in countries where beliefs about gender equality are more widespread."
Study's Limits
Many potential participants refused to take the survey. No one knows if their views match those noted in the study.
Also, the surveys weren't given the same way worldwide, which could have affected the results, the researchers note. For instance, the surveys were done by telephone in many Western countries, by mail in Japan, door-to-door in the Middle East and South Africa, and in public places in Asian countries except Japan.
People who hadn't been sexually active in the past year weren't included in some of the results, including those related to sex's impact on overall happiness.
The study was funded by the drug company Pfizer. However, the researchers state in the journal that Pfizer had no input on how the researchers analyzed, interpreted, and reported the findings.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


